NKA Bio

NKA Bio is a healthcare company in Baltimore, United States, founded in 2024. It has raised $1.3M across 4 rounds, most recently a $1.3M Grant in November 2025.

When minutes count, our antibody buys hours.

Employees
1–10
Founded
2024
Website
nkabio.com
Total Funding
$1.3M
Last Round
$1.3M GrantNov 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 1 investor for this company. The full record is or through the API.

About

NKA Bio is a biotech startup developing novel antibody therapeutics for critically ill trauma patients. Founded on research by the first Director of Emergency Medicine at Johns Hopkins, NKA Bio's lead candidate NKA01 is a monoclonal antibody designed to neutralize the body's shock response — pressing pause on death with a low-volume prefilled syringe injection by EMS at the point of injury to buy more time for transport and life-saving surgery. The company operates R&D facilities in Baltimore, Maryland equipped for antibody engineering and assay development, with a lead candidate on a path to enter the clinic.

Summary

It lists 1–10 employees. It has raised $1.3M in total across 4 rounds, most recently a $1.3M Grant round in Nov 2025. Investors include Techstars.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
GrantNov 2025
$1.3M

Sign up to see all 4 events

Funding: Seed through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NKA Bio on Indexed.vc
<a href="https://indexed.vc/companies/nka-bio"><img src="https://indexed.vc/api/badge/company/nka-bio" alt="NKA Bio on Indexed.vc" width="260" height="76" /></a>